Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 25, Issue 1, Pages 757-765
Publisher
Informa UK Limited
Online
2018-03-12
DOI
10.1080/10717544.2018.1446474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RGD-decorated redox-responsive d-α-tocopherol polyethylene glycol succinate–poly(lactide) nanoparticles for targeted drug delivery
- (2016) Yuanyuan Guo et al. Journal of Materials Chemistry B
- Multi-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging
- (2015) Guojun Chen et al. BIOMATERIALS
- Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood
- (2015) Magdiel Inggrid Setyawati et al. CHEMICAL SOCIETY REVIEWS
- Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB
- (2015) Zhidong Liu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies
- (2015) Guihua Fang et al. RSC Advances
- Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity
- (2015) Gerald J Prud'homme et al. Oncotarget
- Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
- (2014) Yinan Zhong et al. BIOMACROMOLECULES
- Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor Barrier
- (2013) Yutaka Miura et al. ACS Nano
- Neuropilin 1: function and therapeutic potential in cancer
- (2013) Belal Chaudhary et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Studies on lactoferrin nanoparticles of gambogic acid for oral delivery
- (2013) Zhen-Hai Zhang et al. DRUG DELIVERY
- N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study onin situintestinal perfusion
- (2013) Fan Yu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway
- (2013) Hywel D. Williams et al. PHARMACEUTICAL RESEARCH
- αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
- (2012) Nora Graf et al. ACS Nano
- Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
- (2012) Xu Wang et al. Anti-Cancer Agents in Medicinal Chemistry
- A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
- (2012) Stephanie D. Steichen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
- (2012) Subramanian Selvamuthukumar et al. Lipids in Health and Disease
- RGD modified albumin nanospheres for tumour vasculature targeting
- (2010) Praveen K. Dubey et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells
- (2009) Hongyan Gu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells
- (2008) Qi Qi et al. Biochemistry and Cell Biology
- Preparation, Physical Properties, and Stability of Gambogic Acid-Loaded Micelles Based on Chitosan Derivatives
- (2008) Xian Zhu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells
- (2008) Hongyan Gu et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now